Gliclazide DIAMIR 30mg Modified-Release Tablet 30’s

Gliclazide DIAMIR 30mg Modified-Release Tablet 30’s

Description:
DIAMIR contains Gliclazide 30 mg, an oral hypoglycemic agent used to help control blood sugar levels in patients with Type 2 Diabetes Mellitus. It works by stimulating the pancreas to release insulin and is formulated as a modified-release tablet for prolonged blood sugar control.

Uses:
Used to manage Type 2 Diabetes Mellitus by helping lower and control blood sugar levels, especially in patients whose diabetes is not adequately controlled by diet and exercise alone.